“A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION”. International Research Journal of Pharmacy 9, no. 5 (May 18, 2018): 90–99. Accessed July 28, 2026. https://irjponline.org/index.php/irjp/article/view/1071.